OTCM
FRLI
Market cap0USD
May 14, Last price
0.00USD
Name
Frelii Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Frélii, Inc. specializes in delivering personalized, subscription-based health and wellness programs. Through its frelii.com web platform, the company designs individual health assessments and tailored nutrition plans. These plans are meticulously developed by analyzing a comprehensive range of personal data, including genetic information, physiological markers, environmental influences, lifestyle choices, and diagnostic lab results. Additionally, the platform facilitates access to various related health products, such as diagnostic testing kits, custom-compounded pharmacy items, and a selection of nutritional and vitamin supplements. Formerly operating as Vican Resources, Inc., the organization rebranded to Frélii, Inc. in March 2018. The company maintains its headquarters in Lehi, Utah.
Key people
Ian Jenkins
Chief Executive Officer, Chief Financial Officer, Director · since 2017
Sandeep Uppal
Chief Administrative Officer · since 2019
Hans Jenkins
Director, Chief Medical Officer · since 2018
Leslie Norris
Director · since 2019
Legal address
C/O Registered Agents Inc.
401 Ryland Street
Suite 200-A
Reno, NV 89502
US
401 Ryland Street
Suite 200-A
Reno, NV 89502
US
Headquarters
6600 Decarie Boulevard
Suite 220
Montreal, QC H3X 2K4
CA
Suite 220
Montreal, QC H3X 2K4
CA
Previous name
Bayview Corp
Previous name
Xpention Genetics Inc
Previous name
Tremont Fair, Inc.
Previous name
Cancer Detection Corp.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||